The 20 Best Lynch Syndrome Doctors near New Hyde Park, NY

Craig Devoe, MD, MHCM, is Chief of the Don Monti Division of Medical Oncology and Hematology and Associate Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Board certified in Medical Oncology, Dr. Devoe specializes in gastrointestinal malignancies (colorectal cancer, pancreatic cancer), and cutaneous malignancies (malignant melanoma) at the Monter Cancer Center where he maintains an active practice focused on providing compassionate, personalized, evidence-based multi-disciplinary care. In addition, Dr. Devoe is a research investigator through the Northwell Health Cancer Institute s NCORP (NCI Community Oncology Research Program) grant and industry-sponsored trials. He works closely with the Cancer Institute s clinical trials office in terms of medical oversight of processes and operations, having completed a training program in clinical research design through the Harvard School of Public Health. Dr. Devoe has served as a member of the Alliance Audit Committee performing oversight at other nationally based cancer programs. After earning his medical degree from the State University of New York (SUNY) at Stony Brook School of Medicine, Dr. Devoe trained in internal medicine at NYU Langone Long Island and completed his fellowship in Hematology/Oncology at SUNY Stony Brook. Dr. Devoe furthered his leadership and managerial skills by earning a master s in Health Care Management degree from the Harvard School of Public Health. Dr. Devoe is an active member of the American Medical Association and the American Society of Clinical Oncology. Dr. Devoe is rated as a Distinguished provider by MediFind in the treatment of Lynch Syndrome. His top areas of expertise are Pancreatic Cancer, Colorectal Cancer, Familial Colorectal Cancer, Melanoma, and Tissue Biopsy.

Vincent Vinciguerra, MD, is Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Board certified in Internal Medicine, Hematology and Medical Oncology, Dr. Vinciguerra specializes in treating gastrointestinal cancers and breast cancer. As an attending physician at the Monter Cancer Center, Dr. Vinciguerra focuses on providing compassionate, personalized, and evidence-based care. He also has devoted his career to Cancer Control and Prevention programs. He is the principal investigator for the National Cancer Institute (NCI) supported National Community Oncology Research Program which offers clinical trials and innovative therapies for cancer patients. Dr. Vinciguerra has published over 100 journal articles on cancer drug trials and treatments related to his national and international collaborations. Dr. Vinciguerra earned his medical degree and trained in internal medicine at the Georgetown University Medical Center. He completed training in Hematology/Oncology at New York Hospital. Dr. Vinciguerra is an active member of the American Society of Hematology, American Society of Clinical Oncology and the American College of Physicians. Dr. Vinciguerra is rated as a Distinguished provider by MediFind in the treatment of Lynch Syndrome. His top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, Familial Colorectal Cancer, and Colorectal Cancer.

As Director of Quality and Patient Safety for Medical Oncology at the Monter Cancer Center, Dr. Tony Philip is committed to improving clinical outcomes. Board Certified in Hematology and Medical Oncology, Dr. Philip s clinical practice is solely dedicated to the treatment of patients with gastrointestinal cancers and sarcomas (cancers of the soft tissue and bone). He maintains an active medical practice focusing on compassionate, personalized, evidence-based multi-disciplinary care. He participates in research focused on improving the care of patients with these diseases. Currently an Assistant Professor at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Dr. Philip completed his Hematology/Oncology fellowship at North Shore-LIJ and his internal medicine residency at Long Island Jewish Medical Center. Dr. Philip earned his MD at University at Buffalo School of Medicine and Biomedical Sciences. He is an active member of the American Society of Clinical Oncology, Connective Tissue Oncology Society, and American College of Physicians. Dr. Philip completed the Northwell Physician Leadership Development Program and the American Society of Clinical Oncology Quality Program. Dr. Philip is rated as a Distinguished provider by MediFind in the treatment of Lynch Syndrome. His top areas of expertise are Adult Soft Tissue Sarcoma, Undifferentiated Pleomorphic Sarcoma, Rhabdomyosarcoma Embryonal, and Colorectal Cancer.

Martin Weiser is a Colorectal Surgeon in New York, New York. Dr. Weiser is rated as an Elite provider by MediFind in the treatment of Lynch Syndrome. His top areas of expertise are Colorectal Cancer, Anal Cancer, Lynch Syndrome, Ileostomy, and Colostomy.

Anna Levy DO, is Medical Director of Hepatobiliary Malignancies and the Hepatic Artery Pump Infusion Program, based at the Monter Cancer Center. Board certified in Internal Medicine, Hematology, and Medical Oncology, she is an Assistant Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Dr. Levy s scope of clinical practice includes liver, bile duct, esophageal, gastric, colon, rectal, and anal malignancies. She focuses on providing compassionate, personalized, and evidence based multidisciplinary care. Dr. Levy earned her medical degree at the Lake Erie College of Osteopathic Medicine. She trained in Internal Medicine at the Christiana Care Health System and completed her fellowship in Medical Oncology and Hematology at Long Island Jewish Medical Center. An active member of the American Society of Clinical Oncology, she is fluent in Russian. Dr. Levy is rated as an Advanced provider by MediFind in the treatment of Lynch Syndrome. Her top areas of expertise are Familial Colorectal Cancer, Familial Pancreatic Cancer, Anal Cancer, Pancreaticoduodenectomy, and Bone Marrow Aspiration.

Eileen Sheehy-Milano,MD is an attending physician based at the Monter Cancer Center where she has special interests in breast cancer and gastrointestinal cancer. Board certified in Internal Medicine and Medical Oncology, she maintains an active practice where she focuses on compassionate, personalized, evidence based multi-disciplinary care. Prior to moving her practice to the Monter Cancer Center, Dr. Sheehy-Milano practiced for 25 years at Northwell Glen Cove Hospital. She earned her medical degree at the Jefferson College for Health Professions in Philadelphia,Pennsylvania. She trained in Internal Medicine at St. Francis Hospital and Medical Center in Hartford, Connecticut with a chief residency year as part of the U. Conn. health system. She completed a fellowship in Medical Oncology at Baylor College of Medicine in Houston, Texas. An active member of the American Society of Clinical Oncology and the American Medical Association, Dr. Sheehy-Milano is an Assistant Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Dr. Milano is rated as an Advanced provider by MediFind in the treatment of Lynch Syndrome. Her top areas of expertise are Angiosarcoma, Anemia, Breast Cancer, and Paget Disease of the Breast.

Kevin Holcomb is an Oncologist in New Hyde Park, New York. Dr. Holcomb is rated as an Advanced provider by MediFind in the treatment of Lynch Syndrome. His top areas of expertise are Ovarian Cancer, Endometrial Cancer, Cervical Cancer, Salpingo-Oophorectomy, and Lymphadenectomy.

President - New York Surgical SocietyPast President - New York society of Colon and Rectal Surgeons. Dr. Sher is rated as an Advanced provider by MediFind in the treatment of Lynch Syndrome. His top areas of expertise are Gastrointestinal Bleeding, Hernia, Cholecystitis, Hernia Surgery, and Bladder Reconstruction.

John Monson is a Colorectal Surgeon in Great Neck, New York. Dr. Monson is rated as an Advanced provider by MediFind in the treatment of Lynch Syndrome. His top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Lynch Syndrome, Colostomy, and Ileostomy.

Dr. Procaccino was born and raised in Westchester, New York. He graduated Summa Cum Laude from Manhattan College and was elected to Phi Beta Kappa. He went on to receive his Doctorate in Medicine from New York Medical College, and was elected to Alpha Omega Alpha in 1984. Dr. Procaccino relocated to Long Island in 1984 where he began his Internship in General Surgery at North Shore University Hospital. Once he completed his training in General Surgery, he trained as a fellow at the Cleveland Clinic. In 1998, he was asked to assume the role of Chief of Colon and Rectal Surgery at North Shore University Hospital in Manhasset.Dr. Procaccino has been the Director of North Shore University Hospital s Center for Colon and Rectal Diseases since inception. In this capacity, he was charged with the task of forming a Division of Colon and Rectal Surgery for the North Shore University Hospital and Long Island Jewish Hospital Department of Surgery. Dr. Procaccino soon took on the coveted position of Chief of this Division.Perhaps Dr. Procaccino s most significant contribution to the field of Colon and Rectal Surgery is his training of the next generation of surgeons. Since 2003, Dr. Procaccino has been the Director of the North Shore/LIJ Fellowship Program in Colon and Rectal Surgery which is accredited by the American Board of Colon and Rectal Surgery. Dr. Procaccino s clinical interests include Colon & Rectal Cancer, Inflammatory Bowel Disease (Crohn s and Ulcerative Colitis) and Diverticulitis. He performs both laparoscopic and open surgery. Dr. Procaccino is rated as an Advanced provider by MediFind in the treatment of Lynch Syndrome. His top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Gastroesophageal Junction Cancer, Ileostomy, and Hernia Surgery.

John Ricci is a Colorectal Surgeon in Great Neck, New York. Dr. Ricci is rated as an Advanced provider by MediFind in the treatment of Lynch Syndrome. His top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Retroperitoneal Inflammation, Hernia Surgery, and Ileostomy.

"Marc Lehrer Greenwald, MD, is the chief of colorectal clinical services and surgeon-in-chief at North Shore University Hospital. He is a double board-certified colorectal surgeon who specializes in minimally invasive and sphincter sparing techniques to treat a wide range of diseases and disorders of the small intestine, colon, rectum and anus. This includes diverticulitis, Crohn's disease, ulcerative colitis and colorectal cancer.""I'm really fortunate to work with an amazing team at North Shore,"" Dr. Greenwald says. ""They share my passion for helping others, and together, we are making a difference in the lives of so many people.""After receiving his medical degree from the Albert Einstein College of Medicine, Dr. Greenwald completed his residency at Montefiore Medical Center and fellowship in Hartford, Connecticut. He joined Northwell in 1991, and has held many leadership positions at North Shore University Hospital, including president of the medical staff and chair of the medical board.Dr. Greenwald established the Enhanced Recovery Program at North Shore University Hospital, implementing protocols that provide easy, safe and rapid recovery after surgery. ""The program helps patients recover faster, get home to their families sooner and have better results,"" he says. His team also leads the way in delivering the best outcomes and highest quality care, consistently scoring above the national average in quality surveys.As program director of the rectal cancer multidisciplinary team, Dr. Greenwald works closely with other Northwell experts-including medical oncologists, radiation oncologists and colorectal surgeons-to evaluate every patient with rectal cancer. ""It's my job to make sure best practices are used and patients receive individualized care with guided support from start to finish.""Dr. Greenwald is an assistant professor of surgery at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and has won multiple teaching awards, including the Department of Surgery Award for Excellence in Operative Teaching. He is also a Castle Connelly Top Doctor.Decades of being a surgeon have given Dr. Greenwald a greater awareness about his patients. ""It's not just about treating their illness,"" he says. ""It's about understanding their illness as it relates to everything else in their lives. You need that global perspective to truly understand what the patient is going through.""". Dr. Greenwald is rated as an Advanced provider by MediFind in the treatment of Lynch Syndrome. His top areas of expertise are Ogilvie Syndrome, Familial Colorectal Cancer, Diverticular Disease, Hernia Surgery, and Bladder Reconstruction.

Francis Arena is a Hematologist and an Oncologist in New Hyde Park, New York. Dr. Arena is rated as an Advanced provider by MediFind in the treatment of Lynch Syndrome. His top areas of expertise are Angiosarcoma, Inflammatory Breast Cancer, Breast Cancer, and Paget Disease of the Breast.

Anna Kurzyna is a Hematologist and an Oncologist in New Hyde Park, New York. Dr. Kurzyna is rated as an Advanced provider by MediFind in the treatment of Lynch Syndrome. Her top areas of expertise are Hemolytic Crisis, Chronic Lymphocytic Leukemia (CLL), Inflammatory Breast Cancer, and Anemia.

"Douglas Held, MD is a board-certified general and colon and rectal surgeon specializing in hernia surgery and was accredited in 2020 by the Surgical Review Corporation (SRC) as a Surgeon of Excellence in hernia surgery.Dr. Held's relationship with Northwell Health dates back to when he was just a young child, when his uncle served as chairman of anesthesiology at Long Island Jewish Medical Center when it first opened in 1953. After seeing several surgeries performed, he knew it was something he would eventually do, and later in his teenage years he became an operating room tech at the same hospital.After attending medical school at SUNY Health Science Center at Brooklyn, Dr. Held completed both his internship and residency at Long Island Jewish Medical Center. He completed his fellowship training in colorectal surgery at Allentown Hospital-Lehigh Valley Center.As his focus turned more and more to hernias, a common problem for both men and women, Dr. Held recognized that the treatments are not a one-size-fits-all approach. ""Different technologies allow us to provide different ways to help each individual person,"" he says. And Dr. Held is at the forefront of these technologies. As the section director of hernia surgery at LIJ Medical Center, Dr. Held works closely with new innovations in hernia care and is heavily involved in the robotic hernia center at LIJ Valley Stream, which achieved dual accreditations from the SRC as a Center of Excellence in both hernia surgery and robotic surgery.Averaging about 900 cases a year for the better part of three decades, Dr. Held has seen a lot over his career and has become very sensitive to patient feedback and observation. ""You sort of develop a sixth sense,"" he says, and he has become acutely attuned to what works and doesn't work in each individual case.With his expertise in high demand, Dr. Held also works to pass on his knowledge to the next generation of surgeons, training medical students as part of the Initial Clinical Experience (ICE) program at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. With such a longstanding career, its this opportunity to act as mentor that keeps him coming back for more.". Dr. Held is rated as an Experienced provider by MediFind in the treatment of Lynch Syndrome. His top areas of expertise are Hernia, Cholecystitis, Umbilical Hernia, Hernia Surgery, and Colostomy.

"Xinhua Zhu, MD, PhD, is a medical oncologist and hematologist at Monter Cancer Center, where he specializes in treating genitourinary cancer, including cancer of the prostate, kidney, bladder and testicles. He focuses on compassionate, evidence-based care, rooted in his research background.""My research helps me think outside the box when creating treatment plans,"" says Dr. Zhu, ""and enables me to explain to patients the mechanisms behind the treatments I'm using."" His research interests include finding new treatment targets for generating hormone resistance in prostate cancer and metastatic castration-resistant prostate cancer, exploring biomarkers in bladder cancer to guide decisions about chemotherapy, exploring the mechanisms for kidney cancer metastasis, and investigating the effectiveness of immunotherapy for genitourinary cancers.Dr. Zhu earned his medical degree at Suzhou Medical College and practiced internal medicine in China. He obtained his PhD in cancer study at Shanghai Jiao Tong University School of Medicine, then moved to the United States for postdoctoral research training at Memorial Sloan Kettering Cancer Center, an internal medicine residency at Mount Sinai School of Medicine. He attended NYU School of Medicine for fellowship training in hematology and medical oncology.In 2013, he joined Northwell Health, where he regularly meets with a multidisciplinary group of pathologists, radiologists, radiation oncologists, surgical oncologists, geneticists and the Molecular Tumor Board to create treatment plans.As an associate professor at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, he twice received the Medical Oncology/Hematology Fellowship Program Teacher of the Year Award. Dr. Zhu is also a phase 1 cancer research program director at Monter Cancer Center. He is assistant investigator at the Feinstein Institutes for Medical Research, and a member of the American Society of Clinical Oncology, the American Association of Cancer Research, and the Principal Investigator for the Northwell Health NCI Community Oncology Research Program (NCORP)For Dr. Zhu, being able to pursue both scientific investigation and patient care is the best part of his work. ""I can take research from the bench to the bedside, providing people with the best possible treatments,"" he says.". Dr. Zhu is rated as an Experienced provider by MediFind in the treatment of Lynch Syndrome. His top areas of expertise are Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Prostate Cancer, and Chromophobe Renal Cell Carcinoma.

Steven R. Savona, MD, is an attending physician based at the Monter Cancer Center where his major clinical interests include blood disorders such as malignant and non-malignant hematology diseases as well as oncology expertise in the areas of diseases of the skin including melanoma, basal cell cancer and squamous cell cancer; he also sees patients with colorectal cancer and pancreas cancer. Dr. Savona maintains an active medical practice focusing on compassionate, personalized, evidence-based multi-disciplinary care. Board certified in Internal Medicine, Medical Oncology, Hematology and Hospice/Palliative medicine, Dr. Savona is an Assistant Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Dr. Savona is an active participant in the Cancer Control Program of the National Cancer Institute sponsored clinical trials based at Northwell. He is an investigator on cancer control studies, studies for the treatment of cancer of the pancreas as well as squamous cancer of the skin. In prior studies, Dr. Savona has addressed issues such as tobacco dependency and smoking cessation, redeveloping life styles and physical activity levels after completion of chemotherapy, the prevention of infections in patients with impaired immunity and prevention of hot flashes in patients on hormonal therapy. Dr. Savona earned his medical degree from Duke University School of Medicine. He completed both his residency in internal medicine and his fellowship in Medical Oncology/Hematology at New York University Medical Center. Dr. Savona is an active member of the American Society of Hematology and the American Society of Clinical Oncology. Dr. Savona is rated as an Experienced provider by MediFind in the treatment of Lynch Syndrome. His top areas of expertise are Malignant Peripheral Nerve Sheath Tumor, Bone Tumor, Melanoma, Thrombocytopenia, and Bone Marrow Aspiration.

Dr. Crina Vintila is an attending physician double board-certified in medical oncology and hematology, who has served the Long Island community for more than 20 years at the Don Monti Cancer Center at Glen Cove Hospital, Huntington Cancer Institute, and most recently, at the Monter Cancer Center.Being part of the Northwell Health System for more than 2 decades, her practice has focused on delivering individualized, evidence-based patient care, in a multidisciplinary setting, with active participation in research trials. She takes special interest in breast, gastrointestinal, and hematologic malignancies.Dr.Vintila earned her medical degree at the Institute of Medicine and Pharmacy, Bucharest, Romania. She completed internal medicine training at the Weil Cornell / NY Hospital -Booth Memorial Medical Center, and her hematology and medical oncology fellowship at Winthrop University Hospital.Dr.Vintila is fluent in Romanian, Spanish and French. Dr. Vintila is rated as an Experienced provider by MediFind in the treatment of Lynch Syndrome. Her top areas of expertise are ALK-Positive Non-Small Cell Lung Cancer, Squamous Cell Lung Carcinoma, Lung Adenocarcinoma, and Small Cell Lung Cancer (SCLC).

Daniel King, MD PhD, is a gastrointestinal medical oncologist based at the Monter Cancer Center and Director of Research and Development for the Northwell Health Cancer Institute's Center for Genomic Medicine. As an academic oncologist and active researcher, he aims to deliver the latest advances uncovered through clinical trials, breakthrough technologies, and targeted therapies, to his patients. Prior to completing medical school, he pursued scientific investigation aimed at uncovering the underpinnings of cancer. These experiences included a fellowship as a Howard Hughes Research Scholar at the National Institutes of Health and as a PhD student at the Wellcome Sanger Genomic Institute at the University of Cambridge, UK, where he studied genomics and bioinformatics. More recently, Dr. King trained in medical oncology at Stanford University where he conducted translational research in pancreatic cancer and has published in peer reviewed journals. At Northwell, in addition to his active medical practice, he conducts clinical research in partnership with Cold Spring Harbor Laboratory, where he is a clinical scholar in the laboratory of Dr. Dave Tuveson. Dr. King is board certified in Internal Medicine and Medical Oncology and is an active member of the American Association of Cancer Research. Dr. King is rated as an Experienced provider by MediFind in the treatment of Lynch Syndrome. His top areas of expertise are Familial Pancreatic Cancer, Pancreatic Cancer, Ampullary Cancer, and Familial Colorectal Cancer.

Maria Jacqueline Nieto,MD,MSc is an Assistant Professor of Medicine at The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell where she specializes in treating patients with benign and malignant hematological conditions.Dr Nieto is board certified in Internal Medicine and Medical Oncology. Dr Nieto's clinical focus is on myelodysplastic syndromes, myeloproliferative disorders, and lymphomas. She is particularly interested in the care of the elderly with hematological malignancies, evaluating treatment disparities in cancer care, and optimizing cancer and palliative care at the end of life. She is co-investigator on multiple clinical trials focused on the treatment of patients with hematological malignancies. Dr Nieto has a Master of Science degree in Clinical Research from New York University.Dr Nieto is an active member in the American Society of Clinical Oncology and the American Society of Hematology and is fluent in Spanish. Dr. Nieto is rated as an Experienced provider by MediFind in the treatment of Lynch Syndrome. Her top areas of expertise are ALK-Positive Non-Small Cell Lung Cancer, Squamous Cell Lung Carcinoma, Lung Adenocarcinoma, Bone Marrow Aspiration, and Tissue Biopsy.